300039 Shanghai Kaibao Pharmaceutical
- 6.48
- +0.11+1.73%
About Shanghai Kaibao Pharmaceutical Company
The company was founded in 2000 and is mainly engaged in R&D, production and sales of modern traditional Chinese medicines. The modern factory was built with an investment of 0.6 billion yuan and is located in the Shanghai Comprehensive Industrial Development Zone. Listed on the Shenzhen Stock Exchange in 2010, it is one of the first GEM listed companies in Fengxian District. The company is mainly engaged in R&D, production and sales of modern traditional Chinese medicine. The company's main products are phlegm removal series products. Corporate honors: National Comprehensive Assessment of Quality Trustworthy Products - Gureqing; Traditional Chinese Medicine Protected Variety Certificate - Gureqing; 2014 National Quality and Integrity Double Pharmaceutical Enterprise; 2nd China Health Reform Enterprise Support List 2014 Most Socially Influential Enterprise; 2nd China Health Reform Enterprise Support List 2014 Most Socially Influential Enterprise Certificate; 2013 China Model Enterprise of Integrity; 2013 China Model Enterprise of Integrity; 2013 China Model Credit Enterprise Certificate; China Pharmaceutical Daily Executive Director Unit; 2013 Top 20 Most Competitive Pharmaceutical Listed Companies; “2022 Industry Pioneer Award” “National Intellectual Property Advantage” “Companies”, “2022 China's Top 100 Traditional Chinese Medicine Companies,” “2023 Shanghai Top 100 Emerging Industry Enterprises,” and “2023 Shanghai Top 100 Private Manufacturing Enterprises”, etc.
Company Profile
Company Executives
- Name
- Position
- Salary
- jingwei mu
- Chairman, Directors, Nomination Committee Members, Chairman of the Strategy Committee, Audit Committee Member
- 765.30K
- liwang ren
- Directors, Board Secretary
- 357.00K
- jianzhong liu
- Directors, Deputy General Manager, Strategy Committee Member
- 143.20K
- yingbin zhou
- Directors, General Manager, Strategy Committee Member, Member of the Remuneration and Assessment Committee
- 379.60K
- guoming wang
- Directors
- 595.60K
- shuzhong jing
- Directors
- 222.20K
- zuguang ye
- Independent Directors, Strategy Committee Member, Chairman of the Remuneration and Assessment Committee
- 60.00K
- zhenni li
- Independent Directors, Chairman of the Audit Committee, Strategy Committee Member, Nomination Committee Members
- 60.00K
- hong ma
- Independent Directors, Audit Committee Member, Member of the Remuneration and Assessment Committee, Chairman of the Nomination Committee
- --
- congying ma
- Securities Affairs Representative
- --
- dongsheng xue
- Chairman of the Supervisory Board, Auditors
- 350.80K
- keji zhao
- Shareholder Supervisors
- 166.50K
- yingjun zhu
- Deputy General Manager
- 197.30K
- youlong chen
- Chief Financial Officer
- --
- fakai lu
- Employee Supervisors
- 136.00K
No Data
